Media Center

IAVI in the News - 2018

May

Outbreak-focused vaccine coalition earmarks $54.9M for HIV group's Lassa fever effort
IAVI and CEPI form partnership to advance Lassa fever vaccine development.
FiercePharma -- USA -- 22 May

 

India-Netherlands-Sweden collaborative programme on HIV/AIDS research
IAVI joins first-of-its-kind program to address current unmet needs and emerging challenges in HIV/AIDS research.
ANI -- India -- 22 May

 

Why the world should keep the hope for an HIV vaccine
Ethel Makila, Associate Director, Advocacy Policy and Communications, shares highlights from a journalist education session on HIV vaccines hosted by IAVI and partners to commemorate HIV Vaccine Awareness Day.
Posterity Media -- Nigeria -- 21 May

 

Artists Are Using Theater to Raise Awareness About India's HIV Crisis
I am + : Dance Theater on HIV India, a partnership with IAVI, Delhi Dance Theater, PULSE musical ensemble, and I Am Positive India, uses movement to combat stigma on HIV Vaccine Awareness Day.
VICE -- USA/India -- 21 May

 

PSF three decades strong in conducting vaccine research to eradicate HIV epidemic
Dr. Julien M. Nyombayire, a research physician and investigator at Projet San Francisco (PSF) in Rwanda, reflects on PSF's history and contributions to HIV vaccine research.
The New Times -- Rwanda -- 18 May

 

Africa Analysis: Capacity building in HIV vaccine R&D
Dr. Anatoli Kamali, Africa Regional Director for IAVI, discusses the importance of continued partnership toward building African scientific and leadership capacity in HIV vaccine R&D
SciDev.Net -- 18 May

 

The Rise of Broadly Neutralizing Antibodies
AVAC Founder Bill Snow describes the state of research into broadly neutralizing antibodies and its implications for new prevention interventions and vaccine development.
AVAC -- 17 May

 

American Generosity Contributes to Global Impact: HIV Vaccine Awareness Day 2018
Margaret McCluskey, senior technical advisor for HIV Vaccine Research in the USAID Office of HIV/AIDS (OHA), discusses the American government’s central role in HIV vaccine research and development globally, including scientific capacity building in Africa in partnership with IAVI.
USAID blog -- 16 May

 

Experts call for Africa suited vaccines to boost war on AIDS
Dr. Anatoli Kamali and Dr. Marianne Mureithi on the critical need for a vaccine and global collaboration toward improved HIV prevention
Business Daily -- Kenya --15 May

 

Take as Directed: Pursuing a Vaccine for HIVpodcast icon
Dr. Mark Feinberg discusses the landscape of HIV vaccine development and IAVI's role in facilitating HIV vaccine development.
CSIS Global Health Policy Center -- USA -- 3 May

Continue reading